ClinVar Miner

Submissions for variant NM_001042492.3(NF1):c.2032_2034delinsGCA (p.Pro678Ala)

dbSNP: rs1597712318
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV002319199 SCV001174822 uncertain significance Hereditary cancer-predisposing syndrome; Cardiovascular phenotype 2021-01-25 criteria provided, single submitter clinical testing The c.2032_2034delCCGinsGCA variant, located in coding exon 18 of the NF1 gene, results from an in-frame deletion of CCG and insertion of GCA at nucleotide positions 2032 to 2034. This results in the substitution of the proline residue for an alanine residue at codon 678, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
GeneDx RCV003332283 SCV004039682 uncertain significance not provided 2023-09-27 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 25486365)

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.